Navigation Links
Astellas Launches Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
Date:4/1/2009

Arginine vasopressin (AVP) receptor antagonist now available in new premixed formulation

DEERFIELD, Ill., April 1 /PRNewswire/ -- Astellas Pharma US, Inc. today announced the commercial availability of Vaprisol(R) (conivaptan hydrochloride injection) Premixed in 5% Dextrose, a new premixed formulation. Discovered and developed by Astellas, Vaprisol, an arginine vasopressin (AVP) receptor antagonist, is the first and only approved drug indicated for the treatment of both euvolemic and hypervolemic hyponatremia in hospitalized patients.(1) Hyponatremia is a potentially life-threatening condition that occurs when the body's blood sodium level falls significantly below normal.(2) Vaprisol Premixed was approved by the U.S. Food and Drug Administration in October 2008.

The 100mL, single-use premixed formulation of Vaprisol comes in a plastic INTRAVIA(R) Container, a product of Baxter Healthcare Corporation, containing 20mg of conivaptan hydrochloride in 5% dextrose solution. Lactic acid, USP is added for pH adjustment to pH 3.4 to 3.8. The new formulation will make preparation easier for health care providers, as it requires no measuring or mixing.(1) Additionally, it has an expiration date of 24 months, six months longer than the original ampule formulation.(3)

"It is imperative to promptly address hyponatremia in emergency and hospital settings," said Dr. Joseph Verbalis, M.D., Professor of Medicine and Physiology at Georgetown University. "Vaprisol Premixed in 5% Dextrose is a convenient option for quickly preparing treatment for hyponatremia patients."

Hyponatremia is present in approximately 28 percent of patients upon admission into acute hospital care, and another 14 percent acquire the condition while in acute care.(4) Severe cases are medical emergencies that can result in swelling of the brain, respiratory arrest, catastrophic brain damage and de
'/>"/>

SOURCE Astellas Pharma US, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cardiome And Astellas Announce Regulatory Update
2. FDA Approves Additional Indication for Astellas MYCAMINE(R)
3. Astellas/GlaxoSmithKlines Vesicare Has Advantages Over Pfizers Detrol LA/Detrusitol XL in Reducing Episodes of Urge Urinary Incontinence
4. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
5. UPMC Health Plan Launches New Personal Health Record
6. HealthInsuranceFinders.com Launches Video Contest for Young Directors
7. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
8. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
9. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
10. Mannatech Launches Phase One of New Sales and Training Tools
11. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Southborough, MA (PRWEB) May 21, 2013 ... a global leader in the development and standardization ... method, jointly developed by Brunswick Laboratories and the ... measuring antioxidants in foods. This decision comes after ... (ERP) chaired by James Harnly of the U.S. ...
(Date:5/21/2013)... Kansas City, MO (PRWEB) May 21, 2013 ... announcing updated news for women who have used the ... patients filing lawsuits alleging blood clot injuries has increased ... those using popular prescription drugs and devices with the ... can find out if others are experiencing similar side ...
(Date:5/21/2013)... Fulton, MD (PRWEB) May 21, 2013 ... don’t often think about. Not only is it more difficult ... down can become tricky. Fortunately, there are a variety of ... extra help. One such product is the raised toilet seat. ... the floor, making it easier to stand back up or ...
(Date:5/20/2013)... CA (PRWEB) May 21, 2013 USA ... A Transcendent Approach to Peak Performance" won the top ... Non-Fiction Category. Chosen over a multitude of international ... global attention and critical acclaim from both mainstream and ... levels - mentally, physically and spiritually. , ...
(Date:5/20/2013)... 2013 Heritage Woods of Gurnee ... County, Illinois, is hosting Breakfast and Bingo at 8:30 ... is located at 3775 Grand Ave. in Gurnee, Illinois, ... Medicaid, who need some help to maintain their independence. ... games of bingo," says Tammy Temaner-Rosas, Director of Marketing ...
Breaking Medicine News(10 mins):Health News:AOAC International Approves ORAC as First Action Official Method 2Health News:DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits 2Health News:JustHomeMedical.com Launches Raised Toilet Seats Category 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3Health News:Heritage Woods of Gurnee Affordable Assisted Living Community to Host Breakfast and Bingo 2
... The US-China Business,Council (USCBC) today encouraged American ... in China in response to the devastating earthquake,that ... member companies have already pledged several million dollars ... to earthquake victims and many,have established matching funds ...
... release earlier this,year, the FDA issued a Public Health ... and cold products should not,be used to treat infants ... and potentially life-threatening side effects can occur from such,use., ... that OTC cough,and cold medicines not be used for ...
... cholesterol-lowering drugs showed some benefits in preliminary trial ... appear to be associated with a lower risk ... fibrillation in postmenopausal women with coronary disease. , ... atrial fibrillation, but it certainly supports the hypothesis ...
... SAN DIEGO, May 15 - RealAge, Inc., ... Life to the Youngest" and,pursue health and wellness ... Award at the 2008 Pharmaceutical Advertising and Marketing,Excellence ... The,RealAge/ARD Marketing Valtrex(R) campaign was honored in the ...
... HIV/AIDS Fundraising Spectacular Takes Place June 14 & 15 at Paris Las ... ... May 15 It,s an all-original, all-singing,all-dancing musical journey across America when ... production show. The spectacular is staged June 14 and 15 in Le,Theatre ...
... May 15 /PRNewswire-FirstCall/ - SXC Health Solutions, Corp.,("SXC" or ... leading provider of,pharmacy benefits management services, announces that Mark ... CFO, will present at the,FBR Capital Markets 12th Annual ... SXC,s presentation will take place on Thursday, May 29,2008 ...
Cached Medicine News:Health News:US Companies Aid Chinese Earthquake Victims 2Health News:US Companies Aid Chinese Earthquake Victims 3Health News:US Companies Aid Chinese Earthquake Victims 4Health News:US Companies Aid Chinese Earthquake Victims 5Health News:US Companies Aid Chinese Earthquake Victims 6Health News:US Companies Aid Chinese Earthquake Victims 7Health News:Saline is Safe Alternative to Harmful Cough and Cold Products 2Health News:Statins May Help Older Women Control Irregular Heartbeat 2Health News:RealAge Wins Silver PhAME Award 2Health News:Golden Rainbow Takes a Musical Journey for Its 22nd Annual 'Ribbon of Life' Production Show 2
(Date:5/20/2013)... 20, 2013  Upsher-Smith Laboratories, Inc., a specialty ... treatments for diseases of the central nervous system, ... website, upsher-smith.com . The new site celebrates ... of the company,s mission statement – Advancing Pharmacotherapy, ... around people with a story to tell, a ...
(Date:5/20/2013)... , May 20, 2013 /PRNewswire-iReach/ -- Specific Technologies, ... first study demonstrating detection of pathogenic bacteria, including ... and Bacillus anthracis which feature ... list of potential bio-threats. This seminal study, conducted ... Laboratory, Salisbury (DSTL), ...
(Date:5/20/2013)... -- TRACE International today released its Global Enforcement Report ... individuals and government or business entities for bribery and ... 2012 is the third in an annual series from ... "Although the number of outbound enforcement actions fell last ... said Alexandra Wrage , TRACE Founder ...
Breaking Medicine Technology:Upsher-Smith Introduces Newly Redesigned Corporate Website 2Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2TRACE Releases 2012 Global Enforcement Report 2TRACE Releases 2012 Global Enforcement Report 3
... Three Trials FRAZER, Pa., March 17 Cephalon, ... positive results from a phase two clinical trial of ... major depressive disorder in adults with bipolar I disorder. ... by bipolar I disorder, which is characterized by fluctuations ...
... recommendation from the U.S. Preventive Services Task Force (USPSTF) underscores ... and strokes among many adults, the head of Partnership for ... first heart attacks in men and first strokes in women. ... 45 and 79 and to women 55 to 79. ...
Cached Medicine Technology:Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression 2Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression 3Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression 4New Aspirin Recommendation Can Help Prevent Heart Attacks & Strokes, Says Partnership for Prevention 2
Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....
Used to introduce balloon, diagnostic and guiding catheters, or other devices for intervention....
Used to introduce large balloon, closed and non-tapered end catheters or other devices for intervention....
Used for the introduction of catheters, balloons and other vascular devices....
Medicine Products: